Qual é o preço para Notable Labs, Ltd. (NTBL)

O preço para Notable Labs, Ltd. (NTBL) é $0.0202

Qual é a capitalização de mercado para Notable Labs, Ltd. (NTBL)

A capitalização de mercado para Notable Labs, Ltd. (NTBL) é $44.67K

Histórico de Preços de Notable Labs, Ltd. (NTBL)

Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.

Ano	Desempenho
2024	-97.63%
2023	-35.28%
2022	-94.02%
2021	21.62%
2020	45.36%
2019	14.25%
2018	-84.70%
2017	40.20%
2016	-5.03%
2015	-14.31%
2014	0.00%

Ano

Desempenho

2024

-97.63%

2023

-35.28%

2022

-94.02%

2021

21.62%

2020

45.36%

2019

14.25%

2018

-84.70%

2017

40.20%

2016

-5.03%

2015

-14.31%

2014

0.00%

Empresa	Preço da ação	Variação 1a%	País
Vertex Pharmaceuticals Incorporated VRTX.US	$525.78	32.80%	US
Argenx SE ARGX.US	$874.09	35.18%	NL
Lonza Group AG LONN.SW	$746.78	9.21%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.08K	-6.68%	KR
UCB S.A. UCB.BR	$261.19	17.24%	BE

Empresa

Preço da ação

Variação 1a%

País